StonvexLoading…
StonvexCore line items from LWAY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $212.50M | $186.82M | $160.12M | $141.57M |
Operating Income | $16.17M | $13.85M | $17.00M | $2.35M |
Net Income | $13.86M | $9.03M | $11.37M | $924.00K |
EPS (Diluted) | $0.89 | $0.60 | $0.75 | $0.06 |
Total Assets | $105.61M | $90.55M | $81.65M | $69.00M |
Total Liabilities | $19.79M | $18.64M | $21.22M | $21.43M |
Cash & Equivalents | $5.57M | $16.73M | $13.20M | $4.44M |
Free Cash Flow OCF − CapEx | $-16.41M | $6.26M | $12.59M | $538.00K |
Shares Outstanding | 15.23M | 15.10M | 14.69M | 14.64M |